Jw Pharmaceutical

This Phase 3 trial tested a new drug called epaminurad against the standard gout medication febuxostat in 612 adults with gout. The goal was to see if epaminurad could lower uric acid levels more effectively and safely. The study is complete, but results are not yet available.

This completed study looked at nearly 7,000 adults with high cholesterol who switched from taking a statin alone to a combination pill containing Pitavastatin and Ezetimibe. The main goal was to see how much their LDL (bad) cholesterol dropped after 24 weeks. The study was observ…

This study looked at how well the drug Livalozet lowers bad cholesterol (LDL-C) in people with high cholesterol, comparing those with and without diabetes. Over 1,500 adults took part for 24 weeks. The main goal was to measure the change in LDL-C levels from the start of the stud…

This Phase 3 trial tested whether adding a new drug called JW0201 to standard diabetes medications (metformin and another pill) helps lower blood sugar more effectively. The study included 196 adults with type 2 diabetes whose blood sugar was not well controlled on their current …

This Phase 3 trial tested whether adding an experimental drug called JW0201 to standard diabetes medications (metformin and empagliflozin) helps lower blood sugar more effectively. The study involved 200 adults with type 2 diabetes whose blood sugar was not well controlled on the…

This completed Phase 3 trial tested a combination of two drugs, JW0108 and C2407, in 145 adults with high cholesterol (dyslipidemia). The goal was to see if the combo lowers LDL ('bad') cholesterol more effectively and safely than placebo. Researchers measured changes in LDL leve…

This completed Phase 1 study gave 8 healthy men a single dose of radioactive-labelled epaminurad to track how the drug is absorbed, broken down, and eliminated in urine and feces. The goal was purely scientific — to understand the drug's metabolism and recovery — not to treat any…

This early-stage study tested a single dose of epaminurad in 34 healthy adults to see how safe it is and how the body processes it. Participants took the drug under fasting conditions, and researchers measured drug levels in the blood. Since this was a Phase 1 trial in healthy pe…

This completed Phase 1 trial tested how two drugs, epaminurad and C2406, interact when taken together in 18 healthy adults aged 19 to 50. Researchers measured drug levels in the blood and checked for side effects. The goal was to see if combining them is safe and how the body pro…

This early-phase study tested the safety and how the body processes a new drug called epaminurad, alone and with naproxen, in 57 healthy adults. The goal was to check for drug interactions and measure drug levels in the blood. Since it involved only healthy people, it does not te…

This early-stage trial tested whether a single pill containing two medicines (pitavastatin for cholesterol and valsartan for blood pressure) works the same in the body as taking the two pills separately. Fifty-two healthy men took both versions in random order. The study only mea…

This completed Phase 1 trial tested the safety and how the body processes three experimental tablets (JW0104, C2402, and JW0105) in 60 healthy volunteers. Participants took the drugs alone or together under fasting conditions. The study measured drug levels in the blood to unders…